Suchergebnisse - "Jingtao Zhong"

PubPharm (6)

1

Achieving complete remission in metastatic hepatocellular carcinoma with sintilimab plus sorafenib therapy followed by hepatic resection: a case report

in: Frontiers in Oncology | 2024

von Kai Cui | Zhongchao Li | Jingtao Zhong | +4

2

Surgical repair of an aortico-left ventricular tunnel with Takayasu's arteritis

in: Journal of Cardiothoracic Surgery | 2022

von Runqian Sui | Jingtao Zhong | Jie Zi | +1

3

Protocol of notable-HCC: a phase Ib study of neoadjuvant tislelizumab with stereotactic body radiotherapy in patients with resectable hepatocellular carcinoma

in: BMJ Open | 2022

von Lei Li | Lei Zhao | Pengfei Sun | +6

4

Targeting of the COX-2/PGE2 axis enhances the antitumor activity of T7 peptide in vitro and in vivo

in: Drug Delivery | 2021

von Jianrong Yang | Jingtao Zhong | Mi Zhou | +11

5

Meloxicam, a Selective COX-2 Inhibitor, Mediates Hypoxia-Inducible Factor- (HIF-) 1α Signaling in Hepatocellular Carcinoma

in: Oxidative Medicine and Cellular Longevity | 2020

von Yinghong Zhou | Xiaofeng Dong | Peng Xiu | +7

6

Early Identification of Process Deviation Based on the Spatial Correlation of Measurements

in: Chemical Engineering Transactions | 2019

von Fangyuan Ma | Xianyao Han | Dexi Lin | +3

1
[1]